Aller au contenu principal
Profil bibliographique

Dana Venkert

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

3Publications signalées
16Citations signalées
0Affiliations récentes

Les domaines associés

3D Printing in Biomedical ResearchDNA Repair MechanismsCancer Cells and MetastasisBRCA gene mutations in cancerNanoplatforms for cancer theranostics

Les publications récentes

Accès ouvert 2026 article OpenAlex

Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk (Adv. Healthcare Mater. 1/2026)

Marina Green Buzhor, Giuseppe Longobardi, Or Kandli, Anne Krinsky et autres

3D Cancer Models This illustration presents a schematic construction site where tumor masses are built as avatars composed of cancer, immune, stromal cells, and blood vessels. Tools and machines represent advanced 3D technologies, while a truck delivers bacteria to model tumor-microbiome crosstalk, …

0 citations Advanced Healthcare Materials
Accès ouvert 2025 article OpenAlex

Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk

Marina Green Buzhor, Giuseppe Longobardi, Or Kandli, Anne Krinsky et autres

The tumor microenvironment (TME) is a complex and dynamic ecosystem increasingly recognized for its interplay with the microbiome. In colorectal, breast, lung, liver, and brain cancers, bacterial communities and their metabolites are shown to influence tumor progression, immune responses, and therapeutic outcomes. …

il (code pays fourni par la source)

5 citations Advanced Healthcare Materials
Accès ouvert 2025 article OpenAlex

Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via immunotherapy

Rami Khoury, Giuseppe Longobardi, Tania Barnatan, Dana Venkert et autres

Poly (ADP-ribose) polymerase inhibitors (PARPi) have revolutionized the treatment landscape for patients suffering from BRCA1- mutated breast and ovarian cancers. However, responses are not durable. We demonstrate that treatment with the PARPi, niraparib, increases programmed cell death protein-1 ligand (PD-L1) expression in …

il, us, pt (code pays fourni par la source)

11 citations Journal of Controlled Release

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.